GHRP-6

Prompts your pituitary to release a pulse of your own growth hormone — the same job as ipamorelin — rather than injecting GH itself. But the effect people actually feel first and loudest is ravenous hunger within 20–30 minutes. Some run it deliberately for that, to drive appetite when bulking or eating is hard; others run it for the GH-side benefits (recovery, lean mass, sleep) and treat the hunger as a tax.

It’s the founder of the whole category — the 1984 hexapeptide that proved a small synthetic peptide could trigger a real GH pulse, and the template ipamorelin, GHRP-2, and hexarelin were all built from. Its signature is the appetite spike: a strong, ghrelin-driven hunger that’s noticeably more intense than GHRP-2’s and a different planet from ipamorelin’s near-clean profile. That intensity is the entire reason to pick it or skip it — there’s no neutral take on GHRP-6’s hunger.

Mimics ghrelin at the GH-secretagogue receptor (GHS-R1a), triggering a pulse of growth hormone and briefly suppressing somatostatin, the brake on GH release. The same ghrelin-receptor activation that drives the GH pulse also lights up the hypothalamic appetite centers — which is why the hunger and the GH pulse are two faces of one mechanism, not a separable side effect. Because it’s a first-generation, less-selective secretagogue, it also nudges cortisol and prolactin upward more than the cleaner later peptides do. Like the rest of the class, it’s the trigger half of a stack: it fires the pulse, a GHRH analog raises how big that pulse is.

The headline “side effect” is the appetite itself — intense, fast-onset hunger that’s the whole point for some users and a dealbreaker for others. Beyond that: water retention, injection-site reactions, occasional head-rush or flushing, and the carpal-tunnel-type tingling that tracks with elevated GH. Because it’s a first-generation, less-selective secretagogue, it raises cortisol and prolactin somewhat more than ipamorelin or GHRP-2 — usually modest, but it’s the reason the cleaner peptides exist. As with the rest of the class, chronically raising GH/IGF-1 isn’t free and isn’t for anyone with active cancer concerns. And sourcing is unregulated — insist on a certificate of analysis before running anything.

Same logic as the rest of the secretagogues: it’s the pulse trigger, so it’s paired with a GHRH analog like CJC-1295 that raises how much GH each pulse releases. Run together, fasted. Within the GHRP family, the choice between GHRP-6, GHRP-2, and ipamorelin is essentially a hunger dial — GHRP-6 at the high end, ipamorelin at the clean end, GHRP-2 in between — so people pick the one whose appetite effect they want, then stack it with the GHRH analog rather than combining GHRPs.